Intuitive Surgical (NASDAQ:ISRG) Sets New 52-Week Low After Analyst Downgrade

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s share price hit a new 52-week low during trading on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $550.00 to $450.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Intuitive Surgical traded as low as $342.10 and last traded at $346.0910, with a volume of 1394898 shares trading hands. The stock had previously closed at $345.42.

ISRG has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft cut their price target on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a report on Tuesday, June 2nd. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Bank of America cut their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Wells Fargo & Company restated an “overweight” rating and issued a $487.00 price target (down from $654.00) on shares of Intuitive Surgical in a report on Friday. Finally, Leerink Partners reduced their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a report on Friday. Twenty-one investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $523.46.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director owned 239 shares in the company, valued at approximately $113,156.94. The trade was a 67.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock valued at $3,059,135 over the last ninety days. 0.60% of the stock is owned by company insiders.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Some market commentary argues ISRG’s recent correction may have reset expectations, with oversold technical conditions and improving earnings estimate revisions potentially setting up a near-term rebound. Down 15% in 4 Weeks, Here’s Why You Should You Buy the Dip in Intuitive Surgical (ISRG)
• Positive Sentiment: Zacks highlighted Intuitive Surgical as a trending stock with strong growth characteristics, saying the company’s fundamentals and growth profile may appeal to investors looking for long-term outperformance. 3 Reasons Growth Investors Will Love Intuitive Surgical (ISRG)
• Positive Sentiment: Another piece noted investor interest in ISRG remains elevated, suggesting the stock is staying on traders’ radar even after recent weakness. Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Commentary focused on whether investors should prioritize Intuitive Surgical’s current robot sales or its longer-term growth opportunity, reinforcing the debate around valuation versus future expansion. What’s More Important For Intuitive Surgical: Today’s Robots Or Tomorrow’s Growth?
• Negative Sentiment: Several analyst updates were cautious, with firms including Stifel, Sanford C. Bernstein, and Citigroup lowering price targets or expectations, which likely added to the selling pressure on ISRG. Stifel Nicolaus Lowers Intuitive Surgical (NASDAQ:ISRG) Price Target to $550.00

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently made changes to their positions in ISRG. Regent Peak Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 7.2% in the second quarter. Regent Peak Wealth Advisors LLC now owns 800 shares of the medical equipment provider’s stock worth $318,000 after purchasing an additional 54 shares during the last quarter. Hyperion Asset Management Ltd boosted its position in shares of Intuitive Surgical by 49.8% during the second quarter. Hyperion Asset Management Ltd now owns 419,329 shares of the medical equipment provider’s stock valued at $166,759,000 after buying an additional 139,422 shares during the last quarter. Northside Capital Management LLC bought a new stake in Intuitive Surgical during the second quarter worth $669,000. Annex Advisory Services LLC grew its holdings in Intuitive Surgical by 37.4% during the second quarter. Annex Advisory Services LLC now owns 90,943 shares of the medical equipment provider’s stock worth $36,166,000 after buying an additional 24,750 shares in the last quarter. Finally, Tema ETFs LLC raised its position in Intuitive Surgical by 28.8% in the 2nd quarter. Tema ETFs LLC now owns 9,704 shares of the medical equipment provider’s stock valued at $3,859,000 after buying an additional 2,170 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.2%

The firm has a market capitalization of $125.08 billion, a PE ratio of 40.45, a price-to-earnings-growth ratio of 2.80 and a beta of 1.46. The business has a 50-day moving average of $413.94 and a 200 day moving average of $465.58.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 17.09%. The business’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.81 EPS. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.62 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.